SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (198)12/7/2000 11:40:26 AM
From: tuck  Respond to of 1784
 
The more I compare TECH's valuation to QGENF's valuation, the more I like the former, now suffering from the post split blues as QGENF did before it. TECH nibble target is $35.

And a shout out to the lab rats: you heard it here first: SIAL goes the EBay route:

biz.yahoo.com

Since SIAL is two years behind in this (though ahead of its competitors), the awarding of an internet P/S ratio for valuation would result in a significant buying op. <g>

Cheers, Tuck



To: scaram(o)uche who wrote (198)12/8/2000 2:26:39 PM
From: tuck  Read Replies (1) | Respond to of 1784
 
Thanks;

Trickle holds its nose and doubles down on NBSC, 300 shares @ 4 13/16. Good to see the portfolio in the black for a change.

Cheers, Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News